Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | STF-62247 |
Synonyms | |
Therapy Description |
STF-62247 shows selective toxicity and growth inhibition to VHL-deficient renal carcinoma cells (PMID: 18769110, PMID: 30758995). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
STF-62247 | STF-62247 shows selective toxicity and growth inhibition to VHL-deficient renal carcinoma cells (PMID: 18769110, PMID: 30758995). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
VHL negative | renal cell carcinoma | sensitive | STF-62247 | Preclinical | Actionable | In a preclinical study, STF-62247 induced selective cytotoxicity and inhibited tumor growth of renal cell carcinoma cells lacking VHL (PMID: 18769110, PMID: 18598947). | 18769110 18598947 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|